Labiaga, Shielou Mae .
HRN: 24-48-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2024
CEFUROXIME 1.5GM (VIAL)
04/09/2024
04/10/2024
IV
1.5grams
Q8 X 2 Doses
S/P LTCS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes